Shortly after taking reins at BioMarin, CEO Alexander Hardy laid out three paths the company could take for its struggling ...

Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...

Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...

After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...

But if you want to use CRISPR for gene therapy, you must first get the scissors ... its cells carry relatively few antigens, ...

We unpack the shocking ending of Bugonia, complete with insights from screenwriter Will Tracy about what the characters are up to.

The Swiss pharma is paying $12 billion for Avidity Biosciences and its three late-stage antibody oligonucleotide conjugates.

Injecting poly-ICLC directly into prostate tumors before surgery may reawaken immune activity and help transform resistant ...

Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...

In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...